Solventum Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.3B | $8.3B | $8.2B | $8.1B | — |
| Gross profit | $4.5B | $4.6B | $4.7B | $4.7B | — |
| Selling, general & administrative | $3.1B | $2.8B | $2.3B | $2.2B | — |
| Research and development | $739.0M | $775.0M | $758.0M | $767.0M | — |
| Operating income | $2.2B | $1.0B | $1.7B | $1.7B | — |
| Pretax income | $1.7B | $605.0M | $1.7B | $1.7B | — |
| Income tax expense | $157.0M | $127.0M | $321.0M | $349.0M | — |
| Net income | $1.6B | $479.0M | $1.3B | $1.3B | — |
| Balance Sheet | |||||
| Cash and equivalents | $878.0M | $762.0M | $194.0M | — | — |
| Current assets | $3.9B | $3.2B | $2.5B | — | — |
| Total assets | $14.3B | $14.5B | $13.9B | — | — |
| Current liabilities | $3.1B | $2.7B | $1.7B | — | — |
| Total liabilities | $9.2B | $11.5B | $2.3B | — | — |
| Total debt | $5.1B | $8.1B | — | — | — |
| Stockholders' equity | $5.0B | $3.0B | $11.7B | $11.7B | $12.1B |
| Cash Flow Statement | |||||
| Cash from operations | $369.0M | $1.2B | $1.9B | $1.7B | — |
| Depreciation and amortization | $489.0M | $555.0M | $561.0M | $578.0M | — |
| Stock-based compensation | $161.0M | $112.0M | $39.0M | $37.0M | — |
| Capital expenditure | $379.0M | $380.0M | $290.0M | $251.0M | — |
| Free cash flow | -$10.0M | $805.0M | $1.6B | $1.4B | — |
| Impairments | $0 | — | — | — | — |
Shares outstanding 173.2M · Free float 85.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.